Primary aldosteronism (PA) is a state of renin-independent aldosterone secretion that can range from subclinical to overt. Some normotensive individuals for whom PA screening is not routinely recommended are reported to fulfill the loading test criterion used for the diagnosis of PA. Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the development of various endocrine tumors. Cases of PA associated with MEN1 have been reported; however, there has been no previous report on renin-independent aldosterone secretion within a family with MEN1. Herein, we present the case of a normotensive family presenting with both MEN1 and renin-independent aldosterone secretion. A 49-year-old man was admitted to our hospital for PA evaluation owing to the plasma aldosterone concentration/plasma renin activity ratio being greater than the screening cut-off value; the patient was normotensive. The patient had a history of left nephrectomy and adrenalectomy for left renal carcinoma and adrenal tumor at the age of 39 years. Subsequently, he was diagnosed with MEN1 concurrent with primary hyperparathyroidism, insulinoma, and novel gene mutations (c.655-5_655-4insC and c.818delC). The loading tests for PA confirmation, including saline infusion, and furosemide upright and captopril challenge tests, yielded positive findings, confirming a case of renin-independent aldosterone secretion. The patient's mother, brother, and sister were also genetically or clinically diagnosed with MEN1. All of them were also normotensive and confirmed to have renin-independent aldosterone secretion. The coexistence of renin-independent aldosterone secretion and MEN1 within this family suggests a relationship between the 2 entities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852679 | PMC |
| http://dx.doi.org/10.1210/jendso/bvac009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study.
Clin Nutr
January 2025
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States of America; Department of Medicine, Boston VA Healthcare System, Boston, MA 02130, United States of America.
Background & Aims: Renin-independent aldosteronism (RIA) refers to a spectrum of autonomous aldosterone hypersecretion. We aimed to explore the genetical relationship between RIA and metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis.
Methods: We included 125357 participants from the cohort of United Kingdom Biobank.
Characterizing the Origins of Primary Aldosteronism.
Hypertension
December 2024
Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension (J.M.B., B.H., L.C.T., J.M., Y.N., A.J.N., A.V.).
Background: Renin-independent aldosterone production in normotensive people increases risk for developing hypertension. In parallel, normotensive adrenal glands frequently harbor aldosterone-producing micronodules with pathogenic somatic mutations known to induce primary aldosteronism (PA). A deeper understanding of these phenomena would inform the origins of PA and its role in hypertension pathogenesis.
View Article and Find Full Text PDFArticle Synopsis
- Primary aldosteronism is a condition marked by excessive aldosterone production due to adrenal gland lesions, primarily characterized by disrupted regulation of aldosterone synthase (CYP11B2).
- In a study of aldosterone-producing adenomas (APAs) without known mutations, researchers discovered specific mutations in the gene for mucolipin-3 (TRPML3) associated with increased calcium activity and aldosterone production.
- These findings suggest that mutations in TRPML3 may contribute to hormone excess in primary aldosteronism, highlighting the disease's underlying genetic factors and their impact on hypertension.
Primary and "Pre-Primary" Aldosteronism in Resistant Hypertension: A Practical, Pragmatic, and Prudent Approach in Resource-Limited Milieu.
Cureus
October 2024
Endocrinology, Diabetes and Metabolism, Samatvam Endocrinology Diabetes Center, Samatvam: Science and Research for Human Welfare Trust, Bangalore, IND.
Introduction Primary aldosteronism (PA), once considered rare, is now recognized as the most common cause of secondary hypertension, accounting for almost a quarter of resistant hypertension (RH) cases. Despite this, PA remains underdiagnosed, with an extremely low percentage of RH patients undergoing screening. Methods In a specialty diabetes-endocrinology clinic, the aldosterone:renin ratio (ARR) was assessed in 115 consecutive RH patients (ages 21-93 years; 47% male; 87% with type 2 diabetes).
View Article and Find Full Text PDFRelationship Between Renin, Aldosterone, Aldosterone-to-Renin Ratio and Arterial Stiffness and Left Ventricular Mass Index in Young Adults.
Circulation
December 2024
Endocrine Hypertension Group, Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia (R.A.A., P.J.F., J.Y.).
Article Synopsis
- Primary aldosteronism is linked to increased cardiovascular risks and can affect young adults' arterial health and heart structure before clinical symptoms appear.
- This study used data from the Raine Study, analyzing young adults at ages 17 and 27 to investigate the relationships between aldosterone levels, arterial stiffness, and left ventricular mass index (LVMI).
- Results showed that females had higher aldosterone-to-renin ratios than males, and notable associations were found between aldosterone levels and LVMI in males at age 27.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!